Key Points
- Oscar Health CFO Richard Scott Blackley sold 18,750 shares at an average price of $31.74, generating $595,125 and reducing his ownership by 25% to 56,250 shares.
- Oscar Health reported strong quarterly results, with EPS of $1.10 versus the $0.40 consensus and revenue of $4.88 billion, up 70.4% year over year.
- OSCR shares opened at $31.31, near their 52-week high of $33.48. Analysts have a consensus “Hold” rating and an average price target of $26.22, despite some recent target increases and bullish ratings.
Oscar Health, Inc. (NYSE:OSCR - Get Free Report) CFO Richard Scott Blackley sold 18,750 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $31.74, for a total transaction of $595,125.00. Following the sale, the chief financial officer owned 56,250 shares in the company, valued at approximately $1,785,375. This trade represents a 25.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Richard Scott Blackley also recently made the following trade(s):
- On Tuesday, June 2nd, Richard Scott Blackley sold 31,683 shares of Oscar Health stock. The shares were sold at an average price of $21.94, for a total transaction of $695,125.02.
Oscar Health Price Performance
Shares of OSCR opened at $31.31 on Friday. The firm has a 50-day simple moving average of $29.95 and a 200-day simple moving average of $21.37. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $33.48. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The company has a market capitalization of $9.66 billion, a price-to-earnings ratio of 22.36, a price-to-earnings-growth ratio of 0.67 and a beta of 2.36.
Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.70. The firm had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.Oscar Health's quarterly revenue was up 70.4% on a year-over-year basis. During the same period last year, the business posted ($0.89) EPS. On average, equities research analysts anticipate that Oscar Health, Inc. will post 1.54 earnings per share for the current year.
Institutional Trading of Oscar Health
A number of institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in Oscar Health by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company's stock valued at $297,477,000 after buying an additional 540,851 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in Oscar Health by 11.0% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company's stock valued at $132,461,000 after buying an additional 910,320 shares during the period. Morgan Stanley increased its position in shares of Oscar Health by 42.8% in the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company's stock valued at $97,918,000 after buying an additional 2,043,758 shares in the last quarter. Thrive Capital Management LLC lifted its stake in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after buying an additional 1,588,395 shares in the last quarter. Finally, BIT Capital GmbH boosted its position in shares of Oscar Health by 545.0% during the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company's stock worth $88,897,000 after buying an additional 5,227,152 shares during the period. 75.70% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on the company. Piper Sandler restated an "overweight" rating and set a $36.00 target price on shares of Oscar Health in a research note on Tuesday, July 28th. Wells Fargo & Company boosted their price objective on Oscar Health from $20.00 to $27.00 and gave the company an "equal weight" rating in a research report on Thursday, August 13th. Zacks Research raised Oscar Health from a "hold" rating to a "strong-buy" rating in a report on Monday, July 6th. Robert W. Baird set a $27.00 target price on shares of Oscar Health in a research note on Friday, August 7th. Finally, Barclays raised their price objective on shares of Oscar Health from $35.00 to $39.00 and gave the company an "overweight" rating in a research report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, Oscar Health has a consensus rating of "Hold" and an average target price of $26.22.
View Our Latest Stock Analysis on OSCR
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
